UnitedHealth Group (NYSE:UNH) Reaches New 52-Week High Following Analyst Upgrade

Posted by Brenda Bartman on Jun 25th, 2026

UnitedHealth Group Incorporated (NYSE:UNH – Get Free Report)’s share price hit a new 52-week high during mid-day trading on Thursday after Bank of America raised their price target on the stock from $450.00 to $475.00. Bank of America currently has a buy rating on the stock. UnitedHealth Group traded as high as $416.50 and last traded at $414.3790, with a volume of 1304341 shares traded. The stock had previously closed at $405.80.

UNH has been the topic of a number of other reports. Barclays boosted their price target on UnitedHealth Group from $373.00 to $429.00 and gave the stock an “overweight” rating in a research report on Tuesday, May 26th. JPMorgan Chase & Co. boosted their target price on UnitedHealth Group from $420.00 to $466.00 and gave the stock an “overweight” rating in a report on Monday, June 8th. Raymond James Financial raised UnitedHealth Group from a “market perform” rating to an “outperform” rating and set a $330.00 price target for the company in a research report on Wednesday, April 1st. HSBC upgraded shares of UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $300.00 price objective for the company in a research note on Tuesday, April 7th. Finally, Mizuho upped their target price on shares of UnitedHealth Group from $440.00 to $460.00 and gave the stock an “outperform” rating in a research note on Monday, June 8th. One investment analyst has rated the stock with a Strong Buy rating, twenty-one have issued a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $410.79.

Get Our Latest Research Report on UnitedHealth Group

Insider Buying and Selling

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 800 shares of UnitedHealth Group stock in a transaction that occurred on Thursday, April 23rd. The shares were sold at an average price of $355.00, for a total value of $284,000.00. Following the completion of the sale, the chief executive officer owned 17,805 shares of the company’s stock, valued at approximately $6,320,775. The trade was a 4.30% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 0.28% of the company’s stock.

Key UnitedHealth Group News

Here are the key news stories impacting UnitedHealth Group this week:

Positive Sentiment: Bank of America raised its price target on UnitedHealth Group to $475 from $450 and maintained a buy rating, signaling confidence in further upside from current levels.
Positive Sentiment: Analysts expect UnitedHealth’s upcoming Q2 2026 results to show double-digit EPS growth, reinforcing the company’s reputation for steady earnings momentum.
Positive Sentiment: Commentary from Jim Cramer and several value-focused articles highlighted UNH as a long-term buy, which may be helping sentiment around the stock.
Positive Sentiment: Reports that UnitedHealth reached a proposed FTC settlement over insulin rebating practices could lower legal and regulatory uncertainty.
Neutral Sentiment: Multiple media pieces framed UnitedHealth as a top healthcare or value stock, but these were largely opinion-driven and do not add new fundamental information.
Neutral Sentiment: Recent “top healthcare stocks to watch” coverage and other market roundups may be adding visibility, though they are unlikely to materially change the investment thesis on their own.

Institutional Investors Weigh In On UnitedHealth Group

A number of large investors have recently made changes to their positions in UNH. Basecamp Wealth Advisors LLC boosted its holdings in shares of UnitedHealth Group by 4.7% in the first quarter. Basecamp Wealth Advisors LLC now owns 2,262 shares of the healthcare conglomerate’s stock worth $612,000 after buying an additional 101 shares during the last quarter. Redwood Investment Management LLC purchased a new position in shares of UnitedHealth Group during the 1st quarter worth $764,000. Sapient Capital LLC increased its stake in shares of UnitedHealth Group by 24.8% in the 1st quarter. Sapient Capital LLC now owns 3,091 shares of the healthcare conglomerate’s stock worth $836,000 after purchasing an additional 615 shares in the last quarter. Vilga Financial Planning LLC lifted its position in UnitedHealth Group by 4.9% during the first quarter. Vilga Financial Planning LLC now owns 764 shares of the healthcare conglomerate’s stock valued at $207,000 after purchasing an additional 36 shares in the last quarter. Finally, FAS Wealth Partners Inc. increased its position in UnitedHealth Group by 270.7% in the first quarter. FAS Wealth Partners Inc. now owns 11,283 shares of the healthcare conglomerate’s stock worth $3,053,000 after buying an additional 8,239 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Price Performance

The firm has a 50 day moving average price of $379.62 and a 200 day moving average price of $331.17. The stock has a market cap of $376.31 billion, a P/E ratio of 31.31, a P/E/G ratio of 1.65 and a beta of 0.64. The company has a quick ratio of 0.80, a current ratio of 0.80 and a debt-to-equity ratio of 0.69.

UnitedHealth Group (NYSE:UNH – Get Free Report) last released its earnings results on Tuesday, April 21st. The healthcare conglomerate reported $7.23 EPS for the quarter, topping analysts’ consensus estimates of $6.76 by $0.47. The company had revenue of $111.65 billion for the quarter, compared to analysts’ expectations of $109.84 billion. UnitedHealth Group had a net margin of 2.68% and a return on equity of 14.65%. The firm’s revenue was up 2.0% compared to the same quarter last year. During the same quarter last year, the business earned $7.20 EPS. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. On average, analysts forecast that UnitedHealth Group Incorporated will post 18.32 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 23rd. Shareholders of record on Monday, June 15th were paid a $2.32 dividend. This represents a $9.28 dividend on an annualized basis and a yield of 2.2%. The ex-dividend date was Monday, June 15th. This is a boost from UnitedHealth Group’s previous quarterly dividend of $2.21. UnitedHealth Group’s dividend payout ratio (DPR) is currently 70.09%.

UnitedHealth Group Company Profile

(Get Free Report)

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.